NDC 87063-080 – Liothyronine Sodium

Liothyronine Sodium 5 ug/1 · Tablet · Oral

Human Prescription Drug

Product NDC87063-080

Product details

Brand name
Liothyronine Sodium
Generic name
Liothyronine Sodium
Labeler
ASCLEMED USA INC.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA200295
Marketed since
December 3, 2012
Listing expires
December 31, 2027
Pharmacologic class
l-Triiodothyronine

Active ingredients

Uses, dosage, side effects and warnings for Liothyronine Sodium →

Package NDC codes (5)

Package NDCDescriptionSince
87063-080-001000 TABLET in 1 BOTTLE (87063-080-00)Feb 9, 2026
87063-080-01100 TABLET in 1 BOTTLE (87063-080-01)Feb 9, 2026
87063-080-3030 TABLET in 1 BOTTLE (87063-080-30)Feb 9, 2026
87063-080-6060 TABLET in 1 BOTTLE (87063-080-60)Feb 9, 2026
87063-080-9090 TABLET in 1 BOTTLE (87063-080-90)Feb 9, 2026

Other Liothyronine Sodium products